The proposed merger of Sequent Scientific and Viyash Life Sciences, backed by Carlyle, has received overwhelming shareholder support. This ₹8,000-crore merger aims to create a global entity, combining Sequent's animal health focus with Viyash's human health expertise. Hari Babu Bodepudi, the (...)
Site référencé: The Economic Times
The Economic Times
SpiceJet Q1 Results : Airline slips into red with Rs 234 crore YoY loss, revenue falls 36%
5/09/2025
Oyo Q1 FY26 PAT doubles YoY to Rs 200 crore ; revenue grows 47% to Rs 2,019 crore
5/09/2025
Sebi ramped up Jane Street probe due to inadequate data, continued complaints : Reports
5/09/2025
China slaps preliminary anti-dumping duties on some EU pork imports
5/09/2025
The Golden Thumb Rule| Don’t drive with the rearview mirror — Kaustubh Belapurkar on why past performance misleads investors
5/09/2025
Abril Paper Tech shares list at 20% below issue price
5/09/2025
